Cingulate (CINGW) Property, Plant & Equipment (Net) (2021 - 2026)
Powered by 
Analysis
Cingulate (CINGW) Property, Plant & Equipment (Net) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.24 Bn | 625.48 Bn | 17.26 Bn | 23.58 Bn |
| 2 | AbbVie | 441.52 Bn | 434.96 Bn | 12.70 Bn | 5.80 Bn |
| 3 | Merck | 365.75 Bn | 358.60 Bn | 12.21 Bn | 25.74 Bn |
| 4 | Novartis Ag | 266.61 Bn | 258.92 Bn | 11.24 Bn | 10.69 Bn |
| 5 | Pfizer | 159.09 Bn | 147.39 Bn | 10.94 Bn | 19.03 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 113.37 Bn |
| 7 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 34.61 Mn |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 709.47 Mn |
| 9 | United Therapeutics | 21.43 Bn | 18.77 Bn | 683.80 Mn | 1.93 Bn |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - | 1.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.63 Mn |
| Dec 31, 2025 | 1.73 Mn |
| Sep 30, 2025 | 1.69 Mn |
| Jun 30, 2025 | 1.80 Mn |
| Mar 31, 2025 | 1.94 Mn |
| Dec 31, 2024 | 2.10 Mn |
| Sep 30, 2024 | 2.07 Mn |
| Jun 30, 2024 | 2.37 Mn |
| Mar 31, 2024 | 2.46 Mn |
| Dec 31, 2023 | 2.55 Mn |
| Sep 30, 2023 | 2.53 Mn |
| Jun 30, 2023 | 2.69 Mn |
| Mar 31, 2023 | 2.84 Mn |
| Dec 31, 2022 | 2.90 Mn |
| Sep 30, 2022 | 2.85 Mn |
| Jun 30, 2022 | 2.95 Mn |
| Mar 31, 2022 | 3.05 Mn |
| Dec 31, 2021 | 3.15 Mn |